Pharmacodynamic approaches to optimizing beta-lactam therapy
Jared L Crandon1, David P Nicolau
1Center for Anti-Infective Research and Development, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102, USA.
Critical Care Clinics
|December 15, 2010
Summary
Optimizing beta-lactam antibiotic therapy, including penicillin, through prolonged infusion or frequent dosing enhances clinical benefits. Research explores the pharmacology and evidence supporting these effective beta-lactam strategies.
Area of Science:
- Pharmacology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Beta-lactam antibiotics are widely used due to their efficacy and safety.
- Historical observations suggest improved outcomes with extended or more frequent beta-lactam administration.
- Significant research has focused on optimizing beta-lactam dosing strategies.
Purpose of the Study:
- To review the pharmacological principles underlying extended or frequent beta-lactam dosing.
- To present current literature on the clinical benefits of these optimized dosing strategies.
- To provide evidence supporting the effective use of beta-lactam therapy.
Main Methods:
- Literature review of pharmacological data.
- Analysis of contemporary clinical studies on beta-lactam dosing.
- Synthesis of evidence regarding perceived and observed clinical benefits.
Main Results:
- Pharmacological rationale supports enhanced efficacy with prolonged or frequent beta-lactam infusions.
- Clinical literature indicates improved patient outcomes and therapeutic success with optimized dosing.
- Evidence supports the clinical utility of strategies like continuous or frequent intermittent infusions.
Conclusions:
- Optimized beta-lactam dosing strategies, including prolonged infusion and frequent administration, are pharmacologically sound.
- Contemporary evidence supports the clinical benefits of these strategies for various infections.
- Effective use of beta-lactam therapy can be enhanced through tailored dosing regimens.
Related Concept Videos
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:23Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
01:27Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...